Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-20-005098
Filing Date
2020-05-08
Accepted
2020-05-08 17:02:04
Documents
53
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cvm_10q.htm 10-Q 1136051
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF cvm_ex31.htm EX-31 28740
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE cvm_ex32.htm EX-32 7238
  Complete submission text file 0001654954-20-005098.txt   3936776

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cvm-20200331.xml EX-101.INS 714816
5 XBRL TAXONOMY EXTENSION SCHEMA cvm-20200331.xsd EX-101.SCH 49629
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cvm-20200331_cal.xml EX-101.CAL 43417
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cvm-20200331_def.xml EX-101.DEF 66400
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cvm-20200331_lab.xml EX-101.LAB 266446
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cvm-20200331_pre.xml EX-101.PRE 188572
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-11889 | Film No.: 20861520
SIC: 2836 Biological Products, (No Diagnostic Substances)